Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease

R Taliyan, V Kakoty, KC Sarathlal… - Journal of Controlled …, 2022 - Elsevier
For the past several years, dementia, is one of the predominantly observed groups of
symptoms in a geriatric population. Alzheimer's disease (AD) is a progressive memory …

Nanocarriers for Alzheimer's disease: research and patent update

K Pathak, SK Mishra, A Porwal… - Journal of Applied …, 2021 - japsonline.com
Alzheimer's disease (AD) is one of the most progressive neurodegenerative disorders
resulting in cognitive and behavioral impairment in individuals beyond 65 years of age. It is …

Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region

M Agrawal, S Saraf, S Saraf… - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Brain is supposed to be the most complicated part of the body which is very far
from the reach of drug moieties. The drug entry in to the brain region depends upon various …

Nanotechnology to improve the Alzheimer's disease therapy with natural compounds

MJ Ramalho, S Andrade, JA Loureiro… - Drug delivery and …, 2020 - Springer
Alzheimer's disease (AD) is a form of dementia with high impact worldwide, accounting with
more than 46 million cases. It is estimated that the number of patients will be four times …

[HTML][HTML] Nanocarriers as a powerful vehicle to overcome blood-brain barrier in treating neurodegenerative diseases: Focus on recent advances

X Niu, J Chen, J Gao - Asian journal of pharmaceutical sciences, 2019 - Elsevier
Neurodegenerative diseases including Alzheimer's disease, Parkinson's disease,
Huntington disease and amyotrophic lateral sclerosis throw a heavy burden on families and …

Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases

S Hernando, O Gartziandia, E Herran, JL Pedraz… - …, 2016 - Taylor & Francis
Alzheimer's disease and Parkinson's disease are the most common neurodegenerative
diseases worldwide. Despite all the efforts made by the scientific community, current …

Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease

G Karthivashan, P Ganesan, SY Park, JS Kim… - Drug …, 2018 - Taylor & Francis
In recent years, the incidental rate of neurodegenerative disorders has increased
proportionately with the aging population. Alzheimer's disease (AD) is one of the most …

Multifunctional nanocarriers for Alzheimer's disease: befriending the barriers

MA Ansari, T Tripathi, B Venkidasamy, A Monziani… - Molecular …, 2024 - Springer
Neurodegenerative diseases (NDDs) have been increasing in incidence in recent years and
are now widespread worldwide. Neuronal death is defined as the progressive loss of …

Alzheimer's disease targeted nano-based drug delivery systems

G Altinoglu, T Adali - Current Drug Targets, 2020 - ingentaconnect.com
Alzheimer's disease (AD) is the most common neurodegenerative disease, and is part of a
massive and growing health care burden that is destroying the cognitive function of more …

Alzheimer's disease: An overview of major hypotheses and therapeutic options in nanotechnology

M Agarwal, MR Alam, MK Haider, MZ Malik, DK Kim - Nanomaterials, 2020 - mdpi.com
Alzheimer's disease (AD), a progressively fatal neurodegenerative disorder, is the most
prominent form of dementia found today. Patients suffering from Alzheimer's begin to show …